RZ
$3.86
+0.16
(+4.32%)
As of Oct 22, 2026, 9:34 PM EDT
Price history
Rezolute Inc (RZLT) is trading up at $3.86 (+4.32%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Rezolute Inc net income history (FY2017–FY2026)
Net income
| FY2017Jun 2017 | FY2018Jun 2018 | FY2019Jun 2019 | FY2020Jun 2020 | FY2021Jun 2021 | FY2022Jun 2022 | FY2023Jun 2023 | FY2024Jun 2024 | FY2025Jun 2025 | FY2026Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Operating income | −$20.3M | −$28.7M | −$25.9M | −$20.5M | −$22.9M | −$41.8M | −$56.0M | −$70.4M | −$79.9M | −$83.0M |
| Net income | −$20.3M | −$29.9M | −$30.4M | −$20.3M | −$20.9M | −$41.1M | −$51.8M | −$68.5M | −$74.4M | −$77.6M |
| EPS (diluted) | −$1425.00 | −$1350.00 | −$18.41 | −$3.54 | −$2.72 | −$2.32 | −$1.01 | −$1.33 | −$0.98 | −$0.75 |
| Balance sheet | ||||||||||
| Cash and equivalents | $4.49M | $1.65M | $37.6M | $77.4M | $41.0M | $150.4M | $16.0M | $70.4M | $94.1M | $10.6M |
| Total assets | $10.6M | $2.50M | $12.3M | $11.0M | $42.6M | $152.4M | $123.7M | $132.7M | $175.5M | $112.8M |
| Total liabilities | $2.10M | $6.46M | $10.5M | $3.60M | $16.5M | $2.95M | $7.55M | $11.7M | $13.4M | $12.2M |
| Long-term debt | — | $3.42M | $0 | $0 | $14.0M | — | — | — | — | — |
| Shareholders' equity | $8.53M | −$3.96M | $1.75M | $7.37M | $26.1M | $149.5M | $116.2M | $121.0M | $162.1M | $100.7M |
| Cash flow | ||||||||||
| Operating cash flow | −$13.3M | −$14.1M | −$15.3M | −$24.2M | −$20.4M | −$39.6M | −$44.5M | −$57.4M | −$69.1M | −$64.6M |
| Capital expenditure | — | $6.00K | $47.0K | $0 | — | — | $153.0K | — | — | — |
| Free cash flow | — | −$14.1M | −$15.4M | −$24.2M | — | — | −$44.6M | — | — | — |
| Share buybacks | — | — | — | — | — | — | — | $3.00K | — | — |
Net income
| Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25†Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | Q4 FY26†Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$16.9M | −$17.1M | −$20.0M | −$25.9M | −$19.8M | −$24.2M | −$17.4M | −$21.6M |
| Net income | −$15.4M | −$15.7M | −$18.9M | −$24.4M | −$18.1M | −$22.8M | −$16.2M | −$20.5M |
| EPS (diluted) | −$0.22 | −$0.22 | −$0.27 | −$0.27 | −$0.18 | −$0.22 | −$0.16 | −$0.19 |
| Balance sheet | ||||||||
| Cash and equivalents | $10.5M | $8.93M | $14.6M | $94.1M | $9.10M | $11.9M | $11.2M | $10.6M |
| Total assets | $123.4M | $112.0M | $94.7M | $175.5M | $158.7M | $138.6M | $125.5M | $112.8M |
| Total liabilities | $9.97M | $12.4M | $12.2M | $13.4M | $11.5M | $10.6M | $8.63M | $12.2M |
| Shareholders' equity | $113.4M | $99.6M | $82.6M | $162.1M | $147.2M | $128.0M | $116.8M | $100.7M |
| Cash flow | ||||||||
| Operating cash flow | −$16.0M | −$13.7M | −$17.4M | −$22.0M | −$17.4M | −$20.3M | −$13.7M | −$13.1M |
From Rezolute Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in June. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Rezolute Inc
- Headquarters
- Redwood City, California From SEC filings, Oct 2026
Recent News (1)
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International